摘要 |
<p>The invention relates to a combination which comprises : (a) a HDAI; and (b) an anti-metabolite, for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of proliferative diseases, more sp ecifically MDS or AML. The invention also relates to pharmaceutical composit ions comprising such a combination and to a method of treating MDS or AML, i n a mammal, particularly a human, with such a combination. The present inven tion further also relates to a commercial package or product comprising such a combination.</p> |